Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
Argus Health
Express Scripts
Queensland Health
QuintilesIMS
US Department of Justice
Deloitte
AstraZeneca
Fuji

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,624,205

« Back to Dashboard

Summary for Patent: 3,624,205
Title: TREATMENT OF HYPERURICEMIA IN HUMANS
Abstract:The method of treatment and prophylaxis for hyperuricemia, which comprises administering to a human patient a therapeutically effective amount of a compound selected from the class consisting of 4-hydroxy-1-H-pyrazolo(3,4-d)pyrimidine and 4,6-dihydroxy-1-H-pyrazolo(3,4-d)pyrimidine.
Inventor(s): Hitchings; George H. (Yonkers, NY), Falco; Elvira A. (New Rochelle, NY)
Assignee: Burroughs Wellcome & Co. (U.S.A.) Inc. (Tuckahoe, NY)
Application Number:04/633,364
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 3,624,205

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 3,624,205

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom23,055/55Aug 10, 1955
United Kingdom19,863/62May 23, 1962
United Kingdom34,519/62Aug 23, 1962

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Merck
Covington
Farmers Insurance
Novartis
Deloitte
Cerilliant
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot